Summary
In a double-blind crossover study performed at Wood Veterans Administration Center and Milwaukee County General Hospital, the efficacy of ethoheptazine (Zactane®) as an analgesic agent was compared to dextropropoxyphene (65 mg) and placebo. Single oral doses of 150 mg ethoheptazine citrate were administered to 76 patients with chronic pain of various etiologies. The analgesia score obtained for 150 mg ethoheptazine was not significantly different from that obtained for 65 mg dextropropxyphene HCl. Both active medications demonstrated significant analgesic activity compared to placebo. Side effects were minor and did not interfere with the course of therapy.
Similar content being viewed by others
References
Grossman, A.J., Golbey, M., Gittinger, W.C., Batterman, R.C.: Clinical effectiveness and safety of a new series of analgesic compounds. J. Amer. Geriat. Soc.4, 187–192 (1956)
Golbey, M., Leifer, P., Grossman, A.J., Batterman, R.C.: Analgesic effectiveness of orally administered heptacyclazine in man. Fed. Proc.15, 428–429 (1956)
Batterman, R.C., Golbey, M., Grossman, A.J.: Analgesic effectiveness of orally administered ethoheptazine in man. Amer. J. med. Sci.234, 413–419 (1957)
Cass, L.J., Frederick, W.S., Bartholomay, A.F.: Methods in evaluating ethoheptazine and ethoheptazine combined with aspirin. J. Amer. med. Assoc.166, 1829–1833 (1958)
DeKornfeld, T., Lasagna, L.: Clinical trial of two analgesics: WIN 14,098 and ethoheptazine. Fed. Proc. 18, abstract no. 1509 (1959)
Duncan, D.B.: Multiple range and multiple F tests. Biometrics 1–66 (March 1955)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, R.I.H. A controlled clinical comparison of the analgesic efficacy of ethoheptazine, propoxyphene and placebo. Eur J Clin Pharmacol 7, 183–185 (1974). https://doi.org/10.1007/BF00560379
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00560379